Trusted Resources: Education
Scientific literature and patient education texts
Non-Liver Transplant Therapies for ATTR Amyloidosis 2022
source: Amyloidosis Support Groups
year: 2022
authors: Jeffrey Zonder
summary/abstract:Non-Liver Transplant Therapies for ATTR Amyloidosis 2022 lists different medications and therapies for treating ATTR Amyloidosis, a genetic disorder characterized by abnormal deposits of a protein called transthyretin (TTR). The table is divided into 3 categories: Tetramer Stabilizers, RNA-directed Therapies, and Gene Editing Therapies. Some of the therapies listed, such as Patisiran, Tafamidis, Inotersen, and Vutrisiran have FDA approval, while others are still in development.
read more
Related Content
-
CRISPR Injected Into the Blood Treats a Genetic Disease for First TimeThe gene editor CRISPR excels at fixing ...
-
ATTR Treatment Chart – ASG Webinar 7.15.23 – 1/7https://www.youtube.com/watch?v=UcxmPgZ7...
-
Gene Editing Offers Hope for Progressive Cardiomyopathy Due to AmyloidosisInvestigators have found that intravenou...
-
Monoclonal Protein Testing and Wild-Type ATTRhttps://www.youtube.com/watch?v=Vui4kDp3...
-
Symptom Mangement in Cardiac Amyloidosis: Back to Basics – ASG Webinar 3/11https://www.youtube.com/watch?v=K2TmwAfu...
-
Portland — Amyloidosis Support Groups Meeting — LIVE — Saturday, April 20, 2024When: Saturday, April 20, 2024 AL wi...
-
Treatment for ATTR Cardiac Amyloid – ASG Webinar 2/11https://www.youtube.com/watch?v=K2TmwAfu...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.